azomycin has been researched along with ENT Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bataini, JP; Bernier, J; Brugère, J; Brunin, F; de Narbonne, J; Jaulerry, C | 1 |
Lenoir, JL; Pardes, P; Verhulst, J | 1 |
1 trial(s) available for azomycin and ENT Diseases
Article | Year |
---|---|
[Clinical testing of the radiosensitizer RO-07-0582 (misonidazole). Dose tolerance, toxicity and pharmacokinetic studies, preliminary report (author's transl)].
Topics: Bone Neoplasms; Clinical Trials as Topic; Glioma; Humans; Kinetics; Misonidazole; Neoplasms; Nitroimidazoles; Otorhinolaryngologic Diseases; Sarcoma | 1978 |
1 other study(ies) available for azomycin and ENT Diseases
Article | Year |
---|---|
[Evaluation of the use of the combination sulfamethoxazole-trimethoprim-ornidazole in the prevention of infections in major ORL surgery and otoneurosurgery (on 100 cases)].
Topics: Adult; Aged; Bacterial Infections; Drug Combinations; Female; Humans; Male; Middle Aged; Neurosurgery; Nitroimidazoles; Ornidazole; Otorhinolaryngologic Diseases; Postoperative Complications; Premedication; Sulfamethoxazole; Trimethoprim | 1985 |